How Safe for the Patient Is Iodine-131 Therapy for Differentiated Thyroid Carcinoma?

Thomas P. Haynie; Rena Vassilopoulou-Sellin

EditorialHuman Studies

How Safe for the Patient Is Iodine-131 Therapy for Differentiated Thyroid Carcinoma?

Thomas P. Haynie and Rena Vassilopoulou-Sellin

Journal of Nuclear Medicine January 1995, 36 (1) 27-28;

Thomas P. Haynie

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rena Vassilopoulou-Sellin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 36, Issue 1

January 1, 1995

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following How Safe for the Patient Is Iodine-131 Therapy for Differentiated Thyroid Carcinoma?

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.